v3.25.4
Share-based payments
12 Months Ended
Dec. 31, 2025
Disclosure of terms and conditions of share-based payment arrangement [abstract]  
Share-based payments Share-based payments
Accounting for share-based payments
Employee incentives include awards in the form of shares and share options, as well as offering employees the opportunity to purchase
shares on favourable terms. The cost of the employee services received in respect of the shares or share options granted is recognised in
the income statement over the period that employees provide services. The overall cost of the award is calculated using the number of
shares and options expected to vest and the fair value of the shares or options at the date of grant.
The number of shares and options expected to vest takes into account the likelihood that applicable performance and service conditions
included in the terms of the awards will be met. For other share-based payment schemes, such as Sharesave and Sharepurchase, there are
non-vesting conditions which must be met. Failure to meet the non-vesting condition is treated as a cancellation, resulting in an
acceleration of recognition of the cost of the employee services.
The fair value of shares is the market price ruling on the grant date, in some cases adjusted to reflect restrictions on transferability. The
fair value of options granted is determined using the Black-Scholes model to estimate the numbers of shares likely to vest. The model
takes into account the exercise price of the option, the current share price, the risk-free interest rate, the expected volatility of the share
price over the life of the option and other relevant factors. Market conditions that must be met in order for the award to vest are also
reflected in the fair value of the award, as are any other non-vesting conditions – such as continuing to make payments into a share-based
savings scheme.
The charge for the year arising from share-based payment schemes was as follows:
Charge for the year
2025
2024
2023
£m
£m
£m
Share Value Plan and Deferred Share Value Plan
353
319
284
Others
259
178
191
Total equity settled
612
497
475
Cash settled
40
10
4
Total Share-based payments
652
507
479
The terms of the main current plans are as follows:
Share Value Plan (SVP)
SVP awards have been granted to participants in the form of a conditional right to receive Barclays PLC shares or provisional allocations of
Barclays PLC shares which vest or are considered for release over a period of three, four, five or seven years. Participants do not pay to
receive an award or to receive a release of shares. SVP awards are also made to eligible employees for recruitment purposes. All awards are
subject to potential forfeiture in certain leaver scenarios.
Deferred Share Value Plan (DSVP)
The terms of the DSVP are materially the same as the terms of the SVP as described above, save that Executive Directors are not eligible to
participate in the DSVP, and the DSVP operates over market purchase shares only.
Other schemes
In addition to the SVP and DSVP, the Barclays PLC Group operates a number of other schemes settled in Barclays PLC Shares including
Sharesave (both UK and Ireland), Sharepurchase (both UK and overseas), and the Barclays PLC Group Long Term Incentive Plan. A
delivery of upfront shares to ‘Material Risk Takers’ can be made as a Share Incentive Award (Holding Period) under the SVP. A free share
award was delivered under the SVP to all eligible employees in 2025, with this award being subject to a two-year holding period.
Share option and award plans
The weighted average fair value per award granted, weighted average share price at the date of exercise/release of shares during the year,
weighted average contractual remaining life and number of options and awards outstanding (including those exercisable) at the balance sheet
date were as follows:
2025
2024
Weighted
average fair
value per
award
granted in
year
Weighted
average
share price
at exercise/
release
during year
Weighted
average
remaining
contractual
life
Number of
options/
awards
outstanding
Weighted
average fair
value per
award
granted in
year
Weighted
average
share price
at exercise/
release
during year
Weighted
average
remaining
contractual
life
Number of
options/
awards
outstanding
£
£
in years
(000s)
£
£
in years
(000s)
SVP and DSVP1,2
2.86
3.09
1
438,402
1.52
1.74
1
504,825
Others1,3
1.46-3.55
3.04-3.99
0-3
210,182
0.81-2.10
1.71-2.12
0-3
240,029
SVP and DSVP are nil cost awards on which the performance conditions are substantially completed at the date of grant. Consequently, the
fair value of these awards is based on the market value at that date.
Sharesave has a contractual life of 3 years and 5 years, the expected volatility is 29.04% for 3 years and 26.48% for 5 years. The risk-free
interest rates used for valuations are 3.47% and 3.56% for 3 years and 5 years, respectively. The pure dividend yield rates used for valuations
are 1.99% and 2.14% for 3 years and 5 years respectively. The repo rates used for valuations are (0.60)% and (0.69)% for 3 years and 5 years
respectively. The inputs into the model, such as risk-free interest rate, expected volatility, pure dividend yield rates and repo rates are derived
from market data.
Movements in options and awards
The movement in the number of options and awards for the major schemes and the weighted average exercise price of options was:
SVP and DSVP1,2
Others1,3
Number (000s)
Number (000s)
Weighted average exercise
price (£)
2025
2024
2025
2024
2025
2024
Outstanding at beginning of year/acquisition date
504,825
495,724
240,029
288,755
1.19
1.06
Granted in the year
144,110
224,385
102,649
132,013
2.99
1.79
Exercised/released in the year
(190,408)
(191,471)
(123,832)
(163,322)
1.01
0.95
Less: forfeited in the year
(20,125)
(23,813)
(7,874)
(15,164)
1.44
1.19
Less: expired in the year
—
—
(790)
(2,253)
1.19
1.25
Outstanding at end of year
438,402
504,825
210,182
240,029
1.54
1.19
Of which exercisable:
—
—
39,755
25,164
0.95
1.23
Notes:
1Options/award granted over Barclays PLC shares.
2Weighted average exercise price is not applicable for SVP and DSVP awards as these are not share option schemes.
3The number of awards within Others at the end of the year principally relates to Sharesave (number of awards exercisable at end of year was 22,046,433 (2024:
5,343,579)). The weighted average exercise price relates to Sharesave.
Awards and options granted to employees and former employees under the Group’s share plans may be satisfied using new issue shares,
treasury shares and market purchase shares. Awards granted under the DSVP may be satisfied using market purchase shares only.
There were no significant modifications to the share-based payments arrangements in 2025 and 2024.
As at 31 December 2025, the total liability arising from cash-settled employee share-based payments transactions was £40m (2024: £11m).
Holdings of Barclays PLC shares and hedges
Various employee benefit trusts established by the Group hold shares in Barclays PLC to meet obligations under the Barclays share-based
payment schemes. The total number of Barclays shares held in these employee benefit trusts at 31 December 2025 was 20m (2024: 19m).
Dividend rights have been waived on all these shares. The total market value of the shares held in trust based on the year end share price of
£4.80 (2024: £2.68) was £96m (2024: £50m). For accounting of treasury shares, see Note 28.
The Group has entered into physically settled forward contracts to hedge the settlement of certain share-based payment schemes. The fixed
forward price to be paid under these contracts is £30m and has been recorded in retained earnings.